Autistic Feature as a Presentation of Inborn Errors of Metabolism
Iranian Journal of Child Neurology,
Vol. 14 No. 4 (2020),
1 October 2020
,
Page 17-28
https://doi.org/10.22037/ijcn.v14i4.31672
Abstract
Autism spectrum disorder (ASD) is a category of neurodevelopmental disorders characterized by social and communication impairment and restricted or repetitive behaviors. The pathogenesis of ASD is not well understood and it’s proved that genetic is strongly associated with ASD in 5 to 25% of cases. Inborn errors of metabolism(IEMs), defined by a vast array of disorders that are caused by specific enzyme deficiencies or transport protein defects, is as frequent as in 1 in 800 births. IEMs can manifest several psychiatric or behavioral manifestations such as self-injuriesincreased activity and aggression, personality changes, paranoia, depression, catatonia, and psychosis. IEMs underlie autistic symptoms in less than 5% of cases. The literature on the association between ASD and respiratory chain abnormalities is growing, including complex III/IV deficiency and MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes) syndrome, as well as glucose-6-phosphate dehydrogenase deficiency. Google Scholar, Pubmed, and SCOPUS databases were searched using a combination of the following keywords: “autism spectrum disorder”, “autism spectrum”, “autistic feature” and “inborn error of metabolism”, “ IEM”, “congenital error of metabolism”. Initially, 655 articles were found and our expert and methodologist altogether selected 187 articles based on the titles, relevance, and text language.
After reading full texts, 37 studies were selected for review. We think it’s best to consider IEMs in children with syndromic ASD and/or if there is a strong familial history of autism or parental consanguineous marriage.
- Autism
- Inborn Errors of Metabolism
- Autism spectrum disorders
How to Cite
References
References
Hyman, S.L., S.E. Levy, and S.M. Myers, Identification, evaluation, and management
of children with autism spectrum disorder. Pediatrics, 2020. 145(1).
Association, A.P., Autism spectrum disorder. In: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, American Psychiatric Association, Arlington, VA 2013. p.50.
WHO, The ICD-10 Classification of Mental and Behavioural Disorders. Clinical descriptions
and diagnostic guidelines. www.who.int/ classifications/icd/en/bluebook.pdf (Accessed on March 28, 2018).
Loomes, R., L. Hull, and W.P.L. Mandy, What is the male-to-female ratio in autism spectrum
disorder? A systematic review and metaanalysis. Journal of the American Academy of
Child & Adolescent Psychiatry, 2017. 56(6): p. 466-474.
Augustyn, M., Autism spectrum disorder: terminology, epidemiology, and pathogenesis. 2019, UpToDate.[Accessed March 2019].
Schaefer, G.B. and R.E. Lutz, Diagnostic yield in the clinical genetic evaluation of autism spectrum disorders. Genet Med, 2006. 8(9): p. 549-56.
Testa, C., et al., Di-(2-ethylhexyl) phthalate and autism spectrum disorders. ASN neuro, 20124(4): p.AN20120015.
Legido, A., R. Jethva, and M.J. Goldenthal. Mitochondrial dysfunction in autism. in Seminars inpediatricneurology. 2013. Elsevier.
Sikora, D.M., et al., The near universal presence of autism spectrum disorders in children with Smith-Lemli-Opitz syndrome. Am J Med Genet A, 2006. 140(14): p. 1511-8.
Schiff, M., et al., Should metabolic diseases be systematically screened in nonsyndromic autism spectrum disorders? PLoS One, 2011. 6(7): p. e21932.
Neggers, Y. The relationship between folic acid and risk of autism spectrum disorders. in Healthcare. 2014 (2). 429-444.
Applegarth, D.A. and J.R. Toone, Incidence of inborn errors of metabolism in British Columbia, 1969–1996. Pediatrics, 2000. 105(1): p. e10-e10.
Lindor, N.M. and P.S. Karnes. Initial assessment of infants and children with suspected inborn errors of metabolism. in Mayo Clinic Proceedings. 1995. Elsevier.
Dhillon, S., J. A Hellings, and M. G Butler, Genetics and mitochondrial abnormalities in autism spectrum disorders: a review. Current Genomics, 2011. 12(5): p. 322-332.
Cleary, M. and A. Green, Developmental delay: when to suspect and how to investigate for an inborn error of metabolism. Archives of disease in childhood, 2005. 90(11): p. 1128-1132.
Spilioti, M., et al., Evidence for treatable inborn errors of metabolism in a cohort of 187 Greek patients with autism spectrum disorder (ASD). Front Hum Neurosci, 2013. 7: p. 858.
Momeni, N., et al., A novel blood-based biomarker for detection of autism spectrumTranslational psychiatry, 2012. 2(3): p. e91-e91.
Aldred, S., et al., Plasma amino acid levels in children with autism and their families. J Autism Dev Disord, 2003. 33(1): p. 93-7.
Anderson, G.M., Chapter 59 - The Neurochemistry of Autism, in Basic Neurochemistry (Eighth Edition), S.T. Brady, et al., Editors. 2012, Academic Press: New York. p. 1012-1020.
De Jaco, A., et al., Unbalance between Excitation and Inhibition in Phenylketonuria, a Genetic Metabolic Disease Associated with Autism. Int J Mol Sci, 2017. 18(5).
Mazlum, B., et al., A late-diagnosed phenylketonuria case presenting with autism spectrum disorder in early childhood. Turk J Pediatr, 2016. 58(3): p. 318-322.
Main, P.A., et al., Folate and methionine metabolism in autism: a systematic review. The American journal of clinical nutrition, 2010. 91(6): p. 1598-1620.
Ali, A., et al., Hyperhomocysteinemia among Omani autistic children: a case-control study. Acta Biochim Pol, 2011. 58(4): p. 547-51.
da Silva, V.C., A.C. de Oliveira, and V. D’Almeida, Homocysteine and psychiatric disorders. Journal of Inborn Errors of Metabolism and Screening, 2017. 5: p. 2326409817701471.
Castro, K., et al., Folic acid and autism: What do we know? Nutr Neurosci, 2016. 19(7): p. 310-7.
de la Bâtie, C.D., et al., Autism spectrum disorders in propionic acidemia patients. Journal
of Inherited Metabolic Disease, 2018. 41(4): p. 623-629.
Zaffanello, M., et al., A Case of Partial Biotinidase Deficiency Associated With Autism. Child Neuropsychology, 2003. 9(3): p.184-188.
Zafeiriou, D.I., et al., L-2-Hydroxyglutaric aciduria presenting with severe autistic features. Brain Dev, 2008. 30(4): p. 305-7.
Lerman-Sagie, T., et al., Should autistic children be evaluated for mitochondrial
disorders? Journal of child neurology, 2004. 19(5): p. 379-381.
Mintz, M., Evolution in the understanding of autism spectrum disorder: historical perspective. The Indian Journal of Pediatrics, 2017. 84(1): p. 44-52.
Clark-Taylor, T. and B.E. Clark-Taylor, Is autism a disorder of fatty acid metabolism? Possible dysfunction of mitochondrial β-oxidation by long chain acyl-CoA dehydrogenase. Medical hypotheses, 2004. 62(6): p. 970-975.
Rose, S., et al., Clinical and molecular characteristics of mitochondrial dysfunction in autism spectrum disorder. Molecular diagnosis & therapy, 2018. 22(5): p. 571-593.
Beaudet, A.L., Hypothesis: Brain carnitine deficiency causes nonsyndromic autism with an extreme male bias. BioEssays: news and reviews in molecular, cellular and developmental biology, 2017. 39(8).
Aydin, H.I., Creatine Transporter Deficiency in Two Brothers with Autism Spectrum Disorder. Indian Pediatr, 2018. 55(1): p. 67-68.
Hendren, R.L., et al., Randomized, placebocontrolled trial of methyl B12 for children with autism. Journal of child and adolescent psychopharmacology, 2016. 26(9): p. 774-783.
Lau, A.A., S.J. Tamang, and K.M. Hemsley,MPS-IIIA mice acquire autistic behaviours with age. J Inherit Metab Dis, 2018. 41(4): p. 669- 677.
Ingudomnukul, E., et al., Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav, 2007. 51(5): p. 597-604.
- Abstract Viewed: 314 times